Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Scandinavian Journal of Immunology|July 1, 1986
Interaction between human IgD and ricinus agglutininR Marches, V GhetieSeminars in Cancer Biology|August 22, 2001
Dormancy in a model of murine B cell lymphomaJ W Uhr, R MarchesProceedings of the National Academy of Sciences of the United States of America|July 21, 1999
Cancer dormancy and cell signaling: induction of p21(waf1) initiated by membrane IgM engagement increases survival of B lymphoma cellsR Marches, R Hsueh, J W UhrProceedings of the National Academy of Sciences of the United States of America|March 15, 2001
A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomasR Marches, E S Vitetta, J W UhrCancer Research|March 4, 1998
Cancer dormancy: role of cyclin-dependent kinase inhibitors in induction of cell cycle arrest mediated via membrane IgMR Marches, R H Scheuermann, J W UhrNeoplasma|January 1, 1990
Treatment of murine EL4 leukemia in ascitic form with anti-Thy 1.2 specific immunotoxinsR Marches, G Mota, M Margineanu, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 7, 2008
Tumor cell dormancy: implications for the biology and treatment of breast cancerT Fehm, V Mueller, R Marches, et al.Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1996
Mouse multivalent IgG(2a, b) antibody--ricin A-chain immunotoxins combined with homologous or heterologous interleukin 2 in the treatment of a murine malignant lymphoproliferation (EL4)G Mota, R Marches, V Cialacu, et al.Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Tumor dormancy and cell signaling: anti-mu-induced apoptosis in human B-lymphoma cells is not caused by an APO-1-APO-1 ligand interactionE Racila, R Hsueh, R Marches, et al.Neoplasma|January 1, 1991
Interleukin 2 enhances the efficiency of immunotoxins in the treatment of mice with ascitic tumorsM Margineanu, R Marches, S Dima, et al.Pageof 2